Furthermore, using Breast Cancer Gene-Expression Miner v4.9 (http://bcgenex.ico.unicancer.fr/BC-GEM/), we observed that the mRNA expression level of TAB182 was lower in breast cancer samples than in healthy (P < 0.0001) or tumor-adjacent samples (P < 0.01) (Fig. 2C). This evidence concerns the gene CNOT12 and breast carcinoma.